Kidney Biopsy Market Forecast 2026: Where the Industry Is Headed

Uncover key drivers, emerging technologies, and competitive movements shaping the kidney biopsy market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Kidney Biopsy Market in 2026, and what figure is it projected to hit by 2030?

The kidney biopsy market size has shown robust growth recently. It is anticipated to expand from $2.26 billion in 2025 to $2.38 billion in 2026, at a compound annual growth rate (CAGR) of 5.4%. The increase observed historically can be attributed to factors such as the rising prevalence of chronic kidney disease, the increasing incidence of glomerulonephritis and nephrotic syndrome, the established clinical reliance on renal biopsy for diagnosis, an increase in kidney transplant procedures, and the expansion of tertiary care hospitals.

The kidney biopsy market is anticipated to experience consistent expansion in the coming years. By 2030, this market is projected to reach a value of $2.86 billion, exhibiting a compound annual growth rate (CAGR) of 4.7%. Factors contributing to this growth include the escalating prevalence of diabetes-related kidney conditions, the expanding implementation of ultrasound- and CT-guided biopsy methods, an elevated need for prompt diagnosis of kidney diseases, continuous progress in imaging technologies, and wider availability of expert nephrology services. Key trends expected during this timeframe encompass a rising inclination towards less invasive kidney biopsy approaches, the increased application of image-guided percutaneous biopsies, a heightened requirement for precise renal disease identification, broader utilization of biopsy methods for transplant surveillance, and enhanced safety and accuracy in obtaining renal tissue samples.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

Which Drivers Are Affecting Market Participation In The Kidney Biopsy Market?

The increasing occurrence of renal cancer is projected to fuel the expansion of the kidney biopsy market in the future. This condition involves the unchecked proliferation of atypical cells within the kidneys. The growing prevalence of renal cancer stems from elements like evolving lifestyles, environmental pollutants, and improved diagnostic methods leading to increased identification of cases. A kidney biopsy aids in both the diagnosis and management of renal cancer by verifying malignant cell presence, assessing the cancer’s severity (grade), guiding treatment strategies, observing the effectiveness of therapies, and offering predictive insights. For example, data from Cancer Research UK, a UK-based cancer research organization, indicates an anticipated rise in new kidney cancer cases from approximately 16,300 in 2023 to about 21,900 in 2025. Consequently, the increased incidence of renal cancer is a key factor propelling the development of the kidney biopsy market.

What Segment Classifications Make Up The Kidney Biopsy Market?

The kidney biopsy market covered in this report is segmented –

1) By Type: Percutaneous Biopsy, Surgical Biopsy

2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria

3) By End-User: Hospitals And Clinics, Tertiary Care Centers, Other End-Users

Subsegments:

1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy, CT-Guided Biopsy

2) By Surgical Biopsy: Open Kidney Biopsy, Laparoscopic Kidney Biopsy

What Trends Are Projected To Support The Growth Of The Kidney Biopsy Market?

Leading companies operating within the kidney biopsy market are developing innovative platforms by integrating artificial intelligence (AI) to enhance diagnostic accuracy, streamline procedures, and improve patient outcomes. Artificial intelligence (AI) elevates kidney biopsy by improving image analysis, providing diagnostic support, aiding in treatment planning, offering predictive analytics, and advancing research in kidney diseases. For instance, in March 2024, Aiosyn, a Netherlands-based software company, launched its NephroPath platform. The NephroPath platform utilizes computational pathology algorithms to analyze histological biomarkers in kidney biopsies, including identifying tissue types, measuring interstitial fibrosis, and precisely counting and assessing glomeruli. This AI-driven analysis ensures consistent, detailed, and reproducible scoring of renal pathology biomarkers, effectively overcoming the drawbacks of traditional scoring methods and observer subjectivity.

Which Key Players Are Driving Competition In The Kidney Biopsy Market?

Major companies operating in the kidney biopsy market are Cardinal Health, Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Hitachi Ltd., Canon Medical Systems Corporation, Cook Medical, B. Braun Melsungen AG, Merit Medical Systems Inc., Argon Medical Devices Inc., Stryker Corporation, Integra LifeSciences Corporation, Leica Biosystems, Hologic Inc., Samsung Medison Co. Ltd., Mindray Medical International Limited, Terumo Corporation, Fujifilm Holdings Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Which Region Currently Holds The Largest Share Of The Kidney Biopsy Market?

North America was the largest region in the kidney biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Kidney Biopsy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16458&type=smp

Browse Through More Reports Similar to the Global Kidney Biopsy Market 2026, By The Business Research Company

Liquid Biopsy Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Kidney Cancer Diagnostics And Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-cancer-diagnostics-and-therapeutics-global-market-report

Kidney Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795